Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Identify which tilts (such as value or quality) tend to be more tax-efficient in retirement index funds and how these choices affect after-tax performance and risk.
24,606 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A rapid attribution study links this summer’s extreme European heat to human-caused climate change, showing europe wa...
A veteran portfolio manager says the real crowded trade is hiding in plain sight, far from the Mag 7 narrative. He po...
The global memory shortage is shaking up pricing and supply chains. This article explains how Apple can actually bene...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
A hypothetical summer of mega-deals could redefine streaming. This article explains what Netflix should consider if F...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
As Hormel gears up for Q1 2026 disclosures, investors want a clear read on margins, demand, and cash flow. This guide...
This guide dives into credo tech (crdo) 2026 Q3 earnings expectations, key drivers, and how investors can position th...
Looking for smart growth amidst market swings? This guide reveals actionable ways to spot stocks double right opportu...
As voice interfaces become a staple in shopping, SoundHound AI could rise as a key AI infrastructure layer. This arti...